Medicalg (MDG) fair value: what the stock is really worth
As of Nov 17, 2026: fair value (intrinsic value) of Medicalg stock PLN 17.59, price PLN 21.40, that is 17.8% below the price, quality 38 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Medicalg
MDG · WARExpensive (fair value 18% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 13, 2026.
How to read this chart
60‑month range 5.75 PLN – 45.00 PLN · fair‑value band 13.19 PLN – 21.98 PLN · the 21.40 PLN price screens above the 17.59 PLN fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 13, 2026.
Every Wednesday you see whether Medicalg is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally.
Show moreShow less
It offers PocketECG, an AI-driven online ECG monitoring device for long-term holter, cardiac event, and mobile cardiac telemetry analysis; Kardiobeat.ai, an AI-Driven lightweight wireless holter monitor; DeepRhythm Platform, a hardware-agnostic cloud-based software that leverages cutting-edge AI technology to detect, classify, analyze, and report ECG data; and DeepRhythmAI, a set of algorithms for heart rhythm analysis that integrates into third-party software and devices.
The company also provides virtual cardiac stress test (VCAST), an AI-based medical system developed for non-invasive, clinical quantitative, and qualitative analysis of CT-scan data, to assess the hemodynamic significance of coronary artery atherosclerotic stenosis.
In addition, it operates ECG TechBot, a software using a set of algorithms for automatic analysis and interpretation of the ECG signal based on deep learning methods.
In addition, the company engages in the provision of information technology and ECG monitoring services; research and development, including the development of artificial intelligence (AI) algorithms and software for arrhythmia diagnostics, as well as the development and commercialization of AI-based VCAST cardiac imaging technology; and production of electromedical equipment.
Medicalgorithmics S.A. company was incorporated in 2005 and is headquartered in Warsaw, Poland.
Stock analysis
Medicalg (MDG) currently trades at 21.40 PLN, while our estimate is 17.59 PLN, 18% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: 13.19 PLN (bear) to 21.98 PLN (bull), the price of 21.40 PLN sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Medicalg reported revenue of 31.0M PLN in FY2025 versus 48.3M PLN in FY2021, a compound −10.5%/yr. Reported net income was −11.7M PLN in FY2025.
Key figures
Market cap 230M PLN (≈ $57.3M) Micro · P/S ratio 6.34 · EPS (TTM) −0.7000 PLN · Net margin −18.3% · Return on equity −10.5% · Return on assets (EBIT) −2.2% (5-year average) · Operating margin −0.1% · Revenue (TTM) 38.3M PLN.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 15 out of 100 (low confidence).
What moves the price
The share trades about 42% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −16% fair-value upside, at −18%, MDG screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
MDG screens overvalued: fair value 18% below the price. Compare with Abbott Laboratories, →
Compare Medicalg with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 401 stocks
Valuation Multiplesvs Medical Devices median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- PEG ratio by industry
- Revenue growth by industry
- Stock screener with 62 metrics
- Valuation of the Poland market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| DexCom, Inc DXCM | $81.61 | $91.66 | +12% | vs MDG |
| Boston Scientific Corporation BSX | $43.69 | $48.77 | +12% | vs MDG |
| Stryker Corporation SYK | $310.72 | $340.60 | +10% | vs MDG |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥185.38 | ¥197.34 | +6% | vs MDG |
| GE HealthCare Technologies Inc GEHC | $82.96 | $69.92 | −16% | vs MDG |
| Siemens Healthineers AG SHL | €43.30 | €34.51 | −20% | vs MDG |
| Edwards Lifesciences Corporation EW | $107.11 | $81.94 | −24% | vs MDG |
| Medtronic plc MDT | $102.88 | $74.89 | −27% | vs MDG |
| Abbott Laboratories, ABT | $107.45 | $75.28 | −30% | vs MDG |
| Koninklijke Philips N.V PHIA | €27.16 | €15.23 | −44% | vs MDG |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Medicalg (MDG) overvalued or undervalued?
What is the fair value of MDG?
What is the quality score of MDG?
What is the price target for Medicalg (MDG)?
What is the Medicalg stock forecast for 2026?
What is the revenue of Medicalg (MDG)?
What is the intrinsic value of Medicalg (MDG)?
Is Medicalg stock overvalued or undervalued in 2026?
Is fair value the same as the market price of MDG?
How much is Medicalg worth?
What do the bullish and bearish scenarios say about MDG?
How solid is the balance sheet of Medicalg (MDG)?
How far is MDG from its 52-week high?
Which stocks are comparable to Medicalg?
Is Medicalg stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Medicalg (MDG)?
What should I pay attention to with Medicalg right now?
Key figures of Medicalg
How large is the market capitalisation of Medicalg (MDG)?
What is the P/S ratio of Medicalg (MDG)?
What are the earnings per share of Medicalg (MDG)?
What is the net margin of Medicalg (MDG)?
What is the return on equity of Medicalg (MDG)?
What is the EBIT return on assets of Medicalg (MDG)?
What is the operating margin of Medicalg (MDG)?
How fast is revenue growing at Medicalg (MDG)?
How much free cash flow does Medicalg (MDG) generate?
How much net debt does Medicalg (MDG) carry?
Watch Medicalg in the live analysis
One click puts Medicalg on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.